Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 5 - Drugs for disorders of the endocrine system
Patents for A61P 5 - Drugs for disorders of the endocrine system (28,908)
08/2012
08/23/2012US20120214771 Compositions for treatment of cardiometabolic disorders
08/23/2012US20120213790 Methods of treatment using il-16 antagonist peptides
08/23/2012US20120213731 Methods and compositions for treating autoimmune diseases
08/22/2012EP2489656A1 Selective androgen receptor modulators (sarms) and uses thereof
08/22/2012EP2488530A1 Spirocyclic piperidine derivatives useful as renin inhibitors
08/22/2012EP2176282B1 8-beta-substituted 16.alpha.-fluoro-estratrienes as selectively active estrogens
08/22/2012EP1841731B1 Substituted aminomethylene sulphonamides, production and use thereof as medicaments
08/22/2012EP1507780B1 Pyrazolo-pyrimidine aniline compounds useful as kinase inhibitors
08/22/2012CN102648183A Substituted pyrazoles as estrogen receptor ligands
08/22/2012CN102647989A Treatment using reprogrammed mature adult cells
08/22/2012CN102643255A Andrographolide compound
08/22/2012CN101649004B Marine oligosaccharide compound with type II diabetes resisting activity and preparation method thereof
08/22/2012CN101014610B 15beta-substituted steroids having selective estrogenic activity
08/21/2012US8247391 Macromolecules, lectins, dextrans, and/or concanavalin A moieties bind reversibly attached to crosslinked particles; sol-gel transformation; drug delivery
08/21/2012US8246987 Controlled release composition and method of producing the same
08/21/2012US8246982 Pressure-sensitive adhesives based on ethylene-vinyl acetate copolymers and adhesive resins, for medical application purposes
08/21/2012CA2473886C Non-steroidal ligands for the glucocorticoid receptor, compositions and uses thereof
08/21/2012CA2371723C Use of (-) (3-trihalomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of insulin resistance, type 2 diabetes, hyperlipidemia and hyperuricemia
08/16/2012WO2012071535A3 Pediatric formulation
08/16/2012US20120208864 Compounds and methods for modulating expression of gcgr
08/16/2012US20120208852 Heterocyclic-substituted 2-acetamido-5-aryl-1,2,4-triazolones and use thereof
08/16/2012US20120208850 Methods, compounds, and compositions for delivering 1,3-propanedisulfonic acid
08/16/2012US20120208836 Compositions and methods for the treatment of obesity and related disorders
08/16/2012US20120208785 Prodrugs of 2,4-Pyrimidinediamine Compounds and Their Uses
08/16/2012US20120208748 Peptide compositions and methods for treating patients
08/16/2012US20120207773 Materials and methods for the development of an antigen-specific immune non-responsiveness state
08/16/2012US20120207769 Inhibitors of IAP
08/16/2012US20120207713 Probiotic bifidobacterium strains
08/16/2012US20120207670 Method for Treating Psoriasis by Administering An Anti-IL-12 Antibody
08/15/2012EP2486024A1 Phenyloxadiazole derivatives as pgds inhibitors
08/15/2012EP2486018A1 Substituted pyrazoles as estrogen receptor ligands
08/15/2012EP2219607B1 Liquid LH formulations
08/15/2012EP1991523B1 Selective androgen receptor modulators
08/15/2012EP1438295B1 Azole derivatives and pharmaceutical compositions containing them
08/15/2012EP1294391B1 Combination of agents for inhibiting transplant rejection
08/15/2012CN102639149A Secreted aP2 and methods of inhibiting same
08/15/2012CN102634432A Desert cistanche and black rice health maintenance wine and production method thereof
08/15/2012CN102631623A Traditional Chinese medicine composite for treating thyroid associated ophthalmopathy and preparation method thereof
08/15/2012CN102631415A Traditional Chinese medicine composite as well as product and application thereof
08/15/2012CN102631312A Compound antithyroid gel for external application and preparation method thereof
08/15/2012CN101896167B Pharmaceutical compositions
08/15/2012CN101721687B Insulin-hydroxyapatite nano compound, preparation method and application thereof
08/15/2012CN101421279B Imidazo compounds
08/15/2012CN101304979B Quinazoline derivative and pharmaceutical
08/14/2012US8242118 Arylsulfonamide derivatives for use as CCR3 antagonists in the treatment of inflammatory and immunological disorders
08/14/2012US8242099 Implants and methods for treating inflammation-mediated conditions of the eye
08/14/2012US8242098 Methods of treating hormone-related conditions using thio-oxindole derivatives
08/14/2012CA2542515C Estrogen extraction from pregnant animal urine
08/14/2012CA2497845C Liquid aerosol formulations and aerosol generating devices and methods for generating aerosols
08/14/2012CA2469028C Pharmaceutical composition in the form of gel or solution based on dihydrotestosterone, preparation method and uses thereof
08/09/2012WO2012104846A1 Ras inhibitors for treating diseases or pathological conditions characterized insulin resistance
08/09/2012WO2012104342A1 Prevention of hypoglycaemia in diabetes mellitus type 2 patients
08/09/2012US20120202996 Tetrahydroquinoline derivatives
08/09/2012US20120202848 Therapy of autoimmune colitis using a tip60 inhibitor
08/09/2012US20120202847 Novel Tetrahydroisoquinoline Compounds
08/09/2012US20120202817 Compounds having 4-pyridylalkylthio group as a substituent
08/09/2012US20120202816 Novel compounds
08/09/2012US20120202805 PI3K (delta) SELECTIVE INHIBITORS
08/09/2012US20120202796 Method for combating adverse effects arising from antipsychotic treatment
08/09/2012US20120202790 [6,6] and [6,7]-bicyclic gpr119 g protein-coupled receptor agonists
08/09/2012US20120202785 Heterocyclic compounds and methods of use
08/09/2012US20120202780 Carrier composition
08/09/2012US20120202742 Methods and devices for the sustained release of multiple drugs
08/09/2012US20120201884 Extracts, fractions and compositions comprising acetogenins and their applications
08/09/2012US20120201876 Method of managing hypercortisolemia, headache disorders, neuropathic pain and related disorders
08/09/2012US20120201872 Liposomes comprising a calcium phosphate-containing precipitate
08/09/2012US20120201831 Human antibodies that bind human il-12 and methods for producing
08/09/2012US20120201747 System and Method for Diagnosis and Treatment
08/09/2012CA2825162A1 Prevention of hypoglycaemia in diabetes mellitus type 2 patients
08/08/2012EP2483308A1 Drug fusions and conjugates with extended half life
08/08/2012EP2483271A1 Pyrazoline dione derivatives as nadph oxidase inhibitors
08/08/2012EP2205253B1 Composition and method inhibiting inflammation
08/08/2012EP1458399B1 Pregnane steroids for use in the treatment of cns disorders
08/08/2012EP1169038B1 Cyclic protein tyrosine kinase inhibitors
08/08/2012CN1439375B Dehydroepiandrosterone treating use and transfer system
08/08/2012CN102627676A C-aryl glucoside sglt2 inhibitors and method
08/08/2012CN102627669A Phosphate ester-containing piperazine derivative and preparation method as well as application thereof
08/08/2012CN102626484A Medicine compound for treating subacute thyroiditis
08/08/2012CN102626396A Metoprolol slow-release tablet and preparation method thereof
08/08/2012CN101148642B Probiotic/non-probiotic combinations
08/07/2012US8236965 Benzimidazole derivatives and their use as a medicament
08/07/2012US8236762 Peptide-cytotoxic conjugates
08/07/2012CA2477737C Multi-substituted selective androgen receptor modulators and methods of use thereof
08/07/2012CA2317721C Novel steroid-activated nuclear receptors and uses therefor
08/02/2012WO2012103411A2 Controlled-release melatonin composition and related methods
08/02/2012WO2012102361A1 Aromatase activator
08/02/2012WO2012101016A1 Testosterone formulations
08/02/2012WO2012100471A1 Traditional chinese medicine for treating polycystic oary syndrome and use thereof
08/02/2012WO2011157443A8 (11β,17α)-11-(4-(2-11C-ACETYL)PHENYL)-17,23-EPOXY- 19,24-DINORCHOLA-4,9,20-TRIEN-3-ONE
08/02/2012US20120196899 Methods and products for treating inflammation
08/02/2012US20120196869 Pyrrolopyrazine-spirocyclic piperidine amides as modulators of ion channels
08/02/2012US20120196863 1,4 oxazines as bace1 and/or bace2 inhibitors
08/02/2012US20120196861 Il17 and ifn-gamma inhibition for the treatment of autoimmune inflammation
08/02/2012US20120196796 Amylin family peptides and methods for making and using them
08/02/2012US20120195968 Controlled-release melatonin compositions and related methods
08/02/2012US20120195892 Immunoglobulin molecules with improved characteristics
08/02/2012CA2824941A1 Testosterone formulations
08/01/2012EP2481747A1 Methods of treating cutaneous flushing using selective alpha-2-adrenergic receptor agonists
08/01/2012EP2481401A1 Lipophilic microparticles containing a protein drug or antigen and formulation comprising same
08/01/2012EP2097385B1 2-[1-phenyl-5-hydroxy or methoxy-4alpha-methyl-hexahydroclopenta[f]indazol-5-yl]ethyl phenyl derivatives as glucocorticoid receptor ligands
1 ... 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 ... 290